Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Severe bleeding and absent ADP-induced platelet aggregation associated with inherited combined CalDAG-GEFI and P2Y12 deficiencies.

Lunghi B, Lecchi A, Santacroce R, Scavone M, Paniccia R, Artoni A, Gachet C, Castaman G, Margaglione M, Bernardi F, Cattaneo M.

Haematologica. 2019 Oct 24. pii: haematol.2019.232850. doi: 10.3324/haematol.2019.232850. [Epub ahead of print]

2.

Patient blood management in cardiac surgery: The "Granducato algorithm".

Scolletta S, Simioni P, Campagnolo V, Celiento M, Fontanari P, Guadagnucci A, Guarracino F, Haxhiademi D, Paniccia R, Simeone F, Ranucci M; Granducato Research Group.

Int J Cardiol. 2019 Aug 15;289:37-42. doi: 10.1016/j.ijcard.2019.01.025. Epub 2019 Jan 11.

PMID:
30711263
3.

On-Treatment Platelet Reactivity is a Predictor of Adverse Events in Peripheral Artery Disease Patients Undergoing Percutaneous Angioplasty.

Grifoni E, Gori AM, Giusti B, Valenti R, Migliorini A, Basili S, Paniccia R, Elmahdy MF, Pulli R, Pratesi C, Antoniucci D, Violi F, Marcucci R.

Eur J Vasc Endovasc Surg. 2018 Oct;56(4):545-552. doi: 10.1016/j.ejvs.2018.06.032. Epub 2018 Jul 17.

4.

Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory Register.

Cini M, Legnani C, Cosmi B, Testa S, Dellanoce C, Paoletti O, Marcucci R, Poli D, Paniccia R, Pengo V, Tripodi A, Palareti G; START-Laboratory Register.

Int J Lab Hematol. 2018 Apr;40(2):229-236. doi: 10.1111/ijlh.12772. Epub 2018 Jan 3.

PMID:
29314632
5.

Residual thrombin potential predicts cardiovascular death in acute coronary syndrome patients undergoing percutaneous coronary intervention.

Attanasio M, Marcucci R, Gori AM, Paniccia R, Valente S, Balzi D, Barchielli A, Carrabba N, Valenti R, Antoniucci D, Abbate R, Gensini GF.

Thromb Res. 2016 Nov;147:52-57. doi: 10.1016/j.thromres.2016.09.020. Epub 2016 Sep 19.

PMID:
27676253
6.

Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study.

Testa S, Legnani C, Tripodi A, Paoletti O, Pengo V, Abbate R, Bassi L, Carraro P, Cini M, Paniccia R, Poli D, Palareti G.

J Thromb Haemost. 2016 Nov;14(11):2194-2201. doi: 10.1111/jth.13486. Epub 2016 Oct 15.

7.

High on-aspirin platelet reactivity predicts cardiac death in acute coronary syndrome patients undergoing PCI.

Gori AM, Grifoni E, Valenti R, Giusti B, Paniccia R, Parodi G, Migliorini A, Antoniucci D, Abbate R, Gensini GF, Marcucci R.

Eur J Intern Med. 2016 May;30:49-54. doi: 10.1016/j.ejim.2015.12.003. Epub 2016 Jan 5. No abstract available.

PMID:
26764084
8.

Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: Results observed in four anticoagulation clinics.

Testa S, Tripodi A, Legnani C, Pengo V, Abbate R, Dellanoce C, Carraro P, Salomone L, Paniccia R, Paoletti O, Poli D, Palareti G; START-Laboratory Register.

Thromb Res. 2016 Jan;137:178-183. doi: 10.1016/j.thromres.2015.12.001. Epub 2015 Dec 2.

PMID:
26672898
9.

A time course study of high on treatment platelet reactivity in acute coronary syndrome male patients on dual antiplatelet therapy.

Fabbri A, Marcucci R, Gori AM, Giusti B, Paniccia R, Balzi D, Barchielli A, Valente S, Giglioli C, Abbate R, Gensini GF.

Thromb Res. 2015 Sep;136(3):613-9. doi: 10.1016/j.thromres.2015.06.040. Epub 2015 Jul 6.

PMID:
26190692
10.

Non-traumatic splenic rupture on dual antiplatelet therapy with aspirin and ticagrelor after stenting for acute coronary syndrome.

Grifoni E, Paniccia R, Giusti B, Sticchi E, Padeletti L, Cavallini C, Marcucci R.

J Cardiol Cases. 2015 Jun 6;12(3):65-67. doi: 10.1016/j.jccase.2015.05.001. eCollection 2015 Sep.

11.

Platelet function tests: a comparative review.

Paniccia R, Priora R, Liotta AA, Abbate R.

Vasc Health Risk Manag. 2015 Feb 18;11:133-48. doi: 10.2147/VHRM.S44469. eCollection 2015. Review.

12.

Residual platelet reactivity to predict long-term clinical outcomes after clopidogrel loading in patients with acute coronary syndromes: comparison of different cutoff values by light transmission aggregometry from the responsiveness to clopidogrel and stent thrombosis 2-acute coronary syndrome (RECLOSE 2-ACS) study.

Valenti R, Marcucci R, Capodanno D, De Luca G, Migliorini A, Gori AM, Parodi G, Giusti B, Carrabba N, Paniccia R, Cantini G, Marrani M, Gensini GF, Abbate R, Antoniucci D.

J Thromb Thrombolysis. 2015 Jul;40(1):76-82. doi: 10.1007/s11239-014-1159-1.

PMID:
25502874
13.

Global platelet hyperreactivity and elevated C-reactive protein levels predict long term mortality in STEMI patients.

Marcucci R, Valente S, Gori AM, Chiostri M, Paniccia R, Giusti B, Cau V, Lazzeri C, Gensini GF, Abbate R.

Thromb Res. 2014 Oct;134(4):884-8. doi: 10.1016/j.thromres.2014.07.020. Epub 2014 Jul 24.

PMID:
25135796
14.

Platelet and leukocyte ROS production and lipoperoxidation are associated with high platelet reactivity in Non-ST elevation myocardial infarction (NSTEMI) patients on dual antiplatelet treatment.

Becatti M, Fiorillo C, Gori AM, Marcucci R, Paniccia R, Giusti B, Violi F, Pignatelli P, Gensini GF, Abbate R.

Atherosclerosis. 2013 Dec;231(2):392-400. doi: 10.1016/j.atherosclerosis.2013.09.030. Epub 2013 Oct 16.

PMID:
24267257
15.

Bioequivalence in the real world is a complex challenge: the case of clopidogrel.

Marcucci R, Paniccia R, Gori AM, Gensini GF, Abbate R.

J Am Coll Cardiol. 2013 Feb 5;61(5):594-5. doi: 10.1016/j.jacc.2012.10.020. Epub 2012 Dec 12. No abstract available.

16.

Perioperative assessment of platelet function by Thromboelastograph Platelet Mapping in cardiovascular patients undergoing non-cardiac surgery.

Cattano D, Altamirano AV, Kaynak HE, Seitan C, Paniccia R, Chen Z, Huang H, Prisco D, Hagberg CA, Pivalizza EG.

J Thromb Thrombolysis. 2013 Jan;35(1):23-30. doi: 10.1007/s11239-012-0788-5.

PMID:
22851059
17.

High on-treatment platelet reactivity by ADP and increased risk of MACE in good clopidogrel metabolizers.

Marcucci R, Giusti B, Paniccia R, Gori AM, Saracini C, Valente S, Giglioli C, Parodi G, Antoniucci D, Gensini GF, Abbate R.

Platelets. 2012;23(8):586-93. doi: 10.3109/09537104.2012.658106. Epub 2012 Mar 5.

PMID:
22390861
18.

Index measured at an intermediate altitude to predict impending acute mountain sickness.

Modesti PA, Rapi S, Paniccia R, Bilo G, Revera M, Agostoni P, Piperno A, Cambi GE, Rogolino A, Biggeri A, Mancia G, Gensini GF, Abbate R, Parati G.

Med Sci Sports Exerc. 2011 Oct;43(10):1811-8. doi: 10.1249/MSS.0b013e31821b55df.

PMID:
21448078
19.

Light transmittance aggregometry induced by different concentrations of adenosine diphosphate to monitor clopidogrel therapy: a methodological study.

Paniccia R, Antonucci E, Maggini N, Miranda M, Romano E, Gori AM, Marcucci R, Prisco D, Abbate R.

Ther Drug Monit. 2011 Feb;33(1):94-8. doi: 10.1097/FTD.0b013e3182052ff4.

PMID:
21192314
20.

High platelet turnover and reactivity in renal transplant recipients patients.

Cesari F, Marcucci R, Gori AM, Caporale R, Fanelli A, Paniccia R, Zanazzi M, Bertoni E, Larti A, Salvadori M, Gensini GF, Abbate R.

Thromb Haemost. 2010 Oct;104(4):804-10. doi: 10.1160/TH10-02-0124. Epub 2010 Aug 5.

PMID:
20694276
21.

High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting.

Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, Buonamici P, Antoniucci D, Abbate R, Gensini GF.

Thromb Haemost. 2010 Aug;104(2):279-86. doi: 10.1160/TH10-01-0007. Epub 2010 May 27.

PMID:
20508896
22.

Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients.

Paniccia R, Antonucci E, Maggini N, Miranda M, Gori AM, Marcucci R, Giusti B, Balzi D, Prisco D, Abbate R.

Thromb Haemost. 2010 Aug;104(2):287-92. doi: 10.1160/TH09-12-0832. Epub 2010 May 10.

PMID:
20458439
23.

eNOS gene influences platelet phenotype in acute coronary syndrome patients on dual antiplatelet treatment.

Fatini C, Sticchi E, Bolli P, Marcucci R, Giusti B, Paniccia R, Gori AM, Gensini GF, Abbate R.

Platelets. 2009 Dec;20(8):548-54. doi: 10.3109/09537100903337401.

PMID:
19891529
24.

Platelet aggregability is modulated by eNOS locus in non-type 2 diabetic patients with acute coronary syndrome.

Fatini C, Sticchi E, Bolli P, Marcucci R, Giusti B, Paniccia R, Gori AM, Gensini GF, Abbate R.

Nutr Metab Cardiovasc Dis. 2011 Jan;21(1):11-7. doi: 10.1016/j.numecd.2009.07.001. Epub 2009 Oct 9.

PMID:
19819117
25.

Effect of blood hematocrit and erythrocyte deformability on adenosine 5'-diphosphate platelet reactivity in patients with acute coronary syndromes on dual antiplatelet therapy.

Cecchi E, Marcucci R, Paniccia R, Bandinelli B, Valente S, Giglioli C, Lazzeri C, Gensini GF, Abbate R, Mannini L.

Am J Cardiol. 2009 Sep 15;104(6):764-8. doi: 10.1016/j.amjcard.2009.05.005. Epub 2009 Jul 18.

PMID:
19733708
26.

Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy.

Paniccia R, Antonucci E, Maggini N, Romano E, Gori AM, Marcucci R, Prisco D, Abbate R.

Am J Clin Pathol. 2009 Jun;131(6):834-42. doi: 10.1309/AJCPTE3K1SGAPOIZ.

PMID:
19461090
27.

Lipid, inflammatory and haemorheological profiles are significantly affected by farmed fish eating: an intervention study.

Sofi F, Gori AM, Cesari F, Paniccia R, Mannini L, Giorgi G, Parisi G, Casini A, Poli BM, Gensini GF, Abbate R.

Int J Food Sci Nutr. 2009;60 Suppl 5:50-9. doi: 10.1080/02652040802379399. Epub 2009 Apr 6.

PMID:
19353368
28.

Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis.

Giusti B, Gori AM, Marcucci R, Saracini C, Sestini I, Paniccia R, Buonamici P, Antoniucci D, Abbate R, Gensini GF.

Am J Cardiol. 2009 Mar 15;103(6):806-11. doi: 10.1016/j.amjcard.2008.11.048. Epub 2009 Jan 24.

PMID:
19268736
29.

Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet function.

Gori AM, Marcucci R, Paniccia R, Giusti B, Fedi S, Antonucci E, Buonamici P, Antoniucci D, Gensini GF, Abbate R.

Thromb Haemost. 2008 Dec;100(6):1136-45.

PMID:
19132241
30.

Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.

Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, Buonamici P, Antoniucci D, Abbate R, Gensini GF.

Circulation. 2009 Jan 20;119(2):237-42. doi: 10.1161/CIRCULATIONAHA.108.812636. Epub 2008 Dec 31.

PMID:
19118249
31.

Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents.

Gori AM, Marcucci R, Migliorini A, Valenti R, Moschi G, Paniccia R, Buonamici P, Gensini GF, Vergara R, Abbate R, Antoniucci D.

J Am Coll Cardiol. 2008 Aug 26;52(9):734-9. doi: 10.1016/j.jacc.2008.05.032.

32.

ADAMTS-13 activity in the presence of elevated von Willebrand factor levels as a novel mechanism of residual platelet reactivity in high risk coronary patients on antiplatelet treatment.

Marcucci R, Cesari F, Cinotti S, Paniccia R, Gensini GF, Abbate R, Gori AM.

Thromb Res. 2008;123(1):130-6. doi: 10.1016/j.thromres.2008.05.017. Epub 2008 Jul 7.

PMID:
18603284
33.

The balance between pro- and anti-inflammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients.

Gori AM, Cesari F, Marcucci R, Giusti B, Paniccia R, Antonucci E, Gensini GF, Abbate R.

Atherosclerosis. 2009 Jan;202(1):255-62. doi: 10.1016/j.atherosclerosis.2008.04.001. Epub 2008 Apr 11.

PMID:
18486134
34.

Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy.

Cesari F, Marcucci R, Caporale R, Paniccia R, Romano E, Gensini GF, Abbate R, Gori AM.

Thromb Haemost. 2008 May;99(5):930-5. doi: 10.1160/TH08-01-0002.

PMID:
18449424
35.

Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients.

Giusti B, Gori AM, Marcucci R, Saracini C, Sestini I, Paniccia R, Valente S, Antoniucci D, Abbate R, Gensini GF.

Pharmacogenet Genomics. 2007 Dec;17(12):1057-64.

PMID:
18004210
36.

Residual platelet reactivity is an independent predictor of myocardial injury in acute myocardial infarction patients on antiaggregant therapy.

Marcucci R, Paniccia R, Antonucci E, Poli S, Gori AM, Valente S, Giglioli C, Lazzeri C, Prisco D, Abbate R, Gensini GF.

Thromb Haemost. 2007 Oct;98(4):844-51.

PMID:
17938810
37.

Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients.

Paniccia R, Antonucci E, Gori AM, Marcucci R, Giglioli C, Antoniucci D, Gensini GF, Abbate R, Prisco D.

J Thromb Haemost. 2007 Sep;5(9):1839-47.

38.

Comparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatment.

Paniccia R, Antonucci E, Gori AM, Marcucci R, Poli S, Romano E, Valente S, Giglioli C, Fedi S, Gensini GF, Abbate R, Prisco D.

Am J Clin Pathol. 2007 Jul;128(1):143-9.

PMID:
17580282
39.

Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis.

Buonamici P, Marcucci R, Migliorini A, Gensini GF, Santini A, Paniccia R, Moschi G, Gori AM, Abbate R, Antoniucci D.

J Am Coll Cardiol. 2007 Jun 19;49(24):2312-7. Epub 2007 Jun 4.

40.

Residual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapy.

Marcucci R, Gori AM, Paniccia R, Giglioli C, Buonamici P, Antoniucci D, Gensini GF, Abbate R.

Atherosclerosis. 2007 Nov;195(1):e217-23. Epub 2007 Jun 6.

PMID:
17555759
41.

Role of glycoprotein Ia gene polymorphisms in determining platelet function in myocardial infarction patients undergoing percutaneous coronary intervention on dual antiplatelet treatment.

Giusti B, Gori AM, Marcucci R, Sestini I, Saracini C, Paniccia R, Poli S, Giglioli C, Valente S, Prisco D, Gensini GF, Abbate R.

Atherosclerosis. 2008 Jan;196(1):341-8. Epub 2006 Dec 8.

PMID:
17157856
42.

Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.

Marcucci R, Paniccia R, Antonucci E, Gori AM, Fedi S, Giglioli C, Valente S, Prisco D, Abbate R, Gensini GF.

Am J Cardiol. 2006 Nov 1;98(9):1156-9. Epub 2006 Aug 31.

PMID:
17056317
43.

Erythrocyte deformability and white blood cell count are associated with aspirin resistance in high-risk vascular patients.

Mannini L, Marcucci R, Paniccia R, Antonucci E, Giglioli C, Valente S, Gori AM, Prisco D, Gensini GF, Abbate R.

Clin Hemorheol Microcirc. 2006;35(1-2):175-81.

PMID:
16899924
44.

Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis.

Biagini MR, Tozzi A, Marcucci R, Paniccia R, Fedi S, Milani S, Galli A, Ceni E, Capanni M, Manta R, Abbate R, Surrenti C.

World J Gastroenterol. 2006 Mar 14;12(10):1607-12.

45.

Reduced erythrocyte deformability and hypercoagulability in idiopathic sudden sensorineural hearing loss.

Mannini L, Paniccia R, Cecchi E, Alessandrello Liotta A, Leprini E, Berloco P, Pagnini P, Abbate R, Franco Gensini G, Prisco D.

Clin Hemorheol Microcirc. 2005;33(1):47-55.

PMID:
16037632
46.

Usefulness of lyophilized calibration plasmas for International Normalized Ratio determination with the bovine combined thromboplastin (Thrombotest): results of a collaborative study.

Chantarangkul V, Frontoni R, Gresele P, Oca G, Paniccia R, Pellegrini L, Tripodi A.

Blood Coagul Fibrinolysis. 2005 Mar;16(2):157-63.

PMID:
15741805
47.

Point-of-Care Testing of Hemostasis in Cardiac Surgery.

Prisco D, Paniccia R.

Thromb J. 2003 May 6;1(1):1.

48.

Thromboxane inhibition improves renal perfusion and excretory function in severe congestive heart failure.

Castellani S, Paniccia R, Di Serio C, La Cava G, Poggesi L, Fumagalli S, Gensini GF, Neri Serneri GG.

J Am Coll Cardiol. 2003 Jul 2;42(1):133-9.

49.

Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test.

Paniccia R, Fedi S, Carbonetto F, Noferi D, Conti P, Bandinelli B, Giusti B, Evangelisti L, Pretelli P, Palmarini MF, Abbate R, Prisco D.

Anesthesiology. 2003 Jul;99(1):54-9.

PMID:
12826842
50.

Plasma and serum levels of D-dimer and their correlations with other hemostatic parameters in pregnancy.

Paniccia R, Prisco D, Bandinelli B, Fedi S, Giusti B, Pepe G, Abbate R.

Thromb Res. 2002 Feb 1;105(3):257-62.

PMID:
11927132

Supplemental Content

Loading ...
Support Center